Home Tags Astellas

Tag: Astellas

Astellas Pharma Inc., Beijing Minhai Biotechnology Co., Ltd – Industry News...

The global “Herpes Zoste Drug market” research report highlights the need for the up-to-date market data for the business management that will offer...

Global Pertussis Vaccine Market 2019 – Astellas Pharma, Minhai Biotechnology, Wuhan...

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell...

Astellas absorbs U.K. ocular gene therapy player Quethera

Japan’s Astellas Pharma has delved deeper into the gene therapy sector, picking up U.K. specialist Quethera for around $109 million. The £85 million deal—split...

Astellas to halt work at R&D subsidiary amid restructuring plan

Astellas Pharma has begun restructuring its operations, with plans to discontinue all work at Astellas Research Technologies, its R&D subsidiary of about 200...

Astellas to pay Aquinox $25M upfront for regional rights to phase...

Astellas is paying Aquinox Pharmaceuticals $25 million upfront for regional rights to rosiptor. The deal gives Astellas the right to develop the phase...

Urovant starts pursuit of Astellas’ overactive bladder drug Myrbetriq with new...

A little later than expected, Roivant group company Urovant has started its confirmatory phase 3 program for overactive bladder (OAB) drug vibegron, originally...

MOST POPULAR

HOT NEWS